European Innovation Council

Sparrow Quantum Aps. is a Danish company focused on advancing quantum technology through the development of light-matter interfaces. It specializes in creating deterministic single-photon sources, which are essential for various quantum applications. The company boasts the highest efficiency in on-chip single-photon sources globally, characterized by superior photon purity, indistinguishability, and outcoupling capabilities. This innovative technology is the culmination of over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which Sparrow Quantum holds exclusive licenses to key patents. By leveraging self-assembled quantum dots integrated with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interaction, providing clients with advanced solutions for their quantum technology needs.

AlzeCure Pharma AB is a pharmaceutical company based in Huddinge, Sweden, that specializes in developing drug therapies aimed at treating diseases affecting the central nervous system, with a particular emphasis on Alzheimer's disease. Established in 2012, the company is advancing multiple drug candidates through its research platforms, NeuroRestore and Alzstatin, among others. Current projects include ACD855, which is undergoing Phase I clinical trials for sleep disruptions, traumatic brain injuries, and Alzheimer's disease, along with several other candidates targeting Alzheimer's: ACD856, ACD679, and ACD680. Additionally, AlzeCure is developing ACD857 for eye and ear conditions, and VR1 for neuropathic pain, alongside TrkA-NAM for osteoarthritic pain. Through its focused research initiatives, AlzeCure Pharma aims to address significant unmet medical needs in neurodegenerative diseases.

Basemark Oy is a technology company based in Espoo, Finland, specializing in performance measurement and augmented reality software for various industries, particularly in automotive applications. Founded in 2015, Basemark develops a suite of benchmarking tools that include Basemark ES 3.1 for graphics performance comparisons, Basemark OS II for system-level performance assessment of smartphones and tablets across multiple platforms, and Basemark X for evaluating gaming and graphics performance. Additionally, it offers Browsermark, which tests browser performance on a range of devices, and Basemark CL for measuring OpenCL implementations. In the automotive sector, Basemark provides a comprehensive suite of augmented reality development tools, enabling original equipment manufacturers and suppliers to create and deploy advanced AR applications for vehicle functions. These tools encompass features such as augmented reality navigation, head-up displays, and AI-based spatial computing, enhancing safety and performance in software-defined vehicles.

Heart Aerospace AB, established in 2018 with headquarters in Gothenburg, Sweden, and operations in Palo Alto, California, specializes in developing electric regional airliners certified for passenger flight. The company's mission is to facilitate swift, affordable, and sustainable travel for regional journeys worldwide. Their flagship aircraft, the ES-19, is a nineteen-passenger electric airliner designed with an operating range of 400 km, aiming to reduce fuel and maintenance costs compared to traditional aircraft while emitting zero operational emissions. Heart Aerospace targets commercial operation certification for the ES-19 by 2026.

ResoTher Pharma is a privately held biotechnology company based in Copenhagen, Denmark. The company specializes in developing peptide-based drugs derived from Annexin A1, an endogenous immunomodulator. These drugs are designed as resolution therapies for diseases where neutrophil-driven inflammation is a key pathological factor. ResoTher Pharma's primary focus is on addressing cardiovascular and inflammatory disorders that have significant unmet medical needs. Their patented peptide drugs target a G-protein coupled receptor expressed on leukocytes, aiming to mimic the body's natural response to resolving inflammation and promoting tissue repair.

Handiscover Sweden AB is an online booking platform specializing in accommodations for individuals with physical disabilities. Founded in 2014 by Sebastien Archambeaud in response to personal experiences as a parent of a child with a muscle disease, the company is headquartered in Malmö, Sweden. Handiscover features a distinctive classification system that allows users to select accommodations based on varying levels of mobility and physical needs. This community-based platform not only enables individuals with disabilities to find suitable vacation rentals but also assists companies and municipalities in gathering and presenting essential accessibility data. By focusing on the unique requirements of its users, Handiscover aims to enhance the travel experience for people with disabilities, making it easier for them to discover and book accessible holiday accommodations.

Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

Sparrow Quantum Aps. is a Danish company focused on advancing quantum technology through the development of light-matter interfaces. It specializes in creating deterministic single-photon sources, which are essential for various quantum applications. The company boasts the highest efficiency in on-chip single-photon sources globally, characterized by superior photon purity, indistinguishability, and outcoupling capabilities. This innovative technology is the culmination of over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which Sparrow Quantum holds exclusive licenses to key patents. By leveraging self-assembled quantum dots integrated with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interaction, providing clients with advanced solutions for their quantum technology needs.

Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

Valo Therapeutics is an immunotherapy company focused on developing antigen-coated oncolytic viruses as therapeutic vaccines for cancer treatment. Founded in 2016 and based in Oxford, United Kingdom, with an additional office in Helsinki, Finland, the company utilizes its innovative Valo Tx platform, which includes PeptiCRAd, an engineered human oncolytic adenovirus. This platform is designed to induce systemic anti-tumor T cell responses by transforming oncolytic adenoviruses into targeted, tissue-specific cancer vaccines without requiring the production of multiple genetically modified viruses. Valo Therapeutics is also advancing other neoantigen strategies, including PeptiENV, in collaboration with Professor Vincenzo Cerullo from the University of Helsinki, to enhance therapeutic responses against various cancer types.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.

Modvion AB is a Swedish company founded in 2015 and based in Gothenburg, specializing in the design and development of modular wind power towers constructed from renewable composite materials. The company focuses on simplifying construction logistics and improving cost efficiency in the wind energy sector through its patented modular technology. This innovative approach enables the production of wind towers exceeding 120 meters in height while significantly reducing transportation costs, installation complexity, and the reliance on traditional steel structures. By leveraging engineered wood products, Modvion aims to enhance the economic viability of wind power projects, ultimately contributing to increased electricity production and more sustainable energy solutions.

Kvantify is a company based in Copenhagen, Denmark, that specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. Founded in 2022, Kvantify focuses on developing solutions that enhance the efficiency of processes such as drug discovery by utilizing advanced computational drug technology. This technology employs proprietary physics-based methods to improve the quality of compounds tested in laboratories, enabling life sciences companies to expedite small molecule research and achieve actionable results. Through its innovative platform, Kvantify aims to deliver significant value to its clients by solving intricate problems in their respective fields.

N2 Applied is a Norwegian technology company focused on enabling farmers to produce their own sustainable fertilizer through an innovative process that utilizes slurry, air, and electricity. The company is in the pre-commercial phase and has developed a technology that allows for the local production of nitrogen-rich fertilizer from liquid organic substrates, such as livestock manure. By integrating nitrogen from the atmosphere into these substrates, N2 Applied's solution not only enhances the nitrogen content but also mitigates ammonia loss and reduces greenhouse gas emissions. The company operates its head office in Oslo/Asker and maintains a test center in Svene, with additional branches in Wageningen and York. N2 Applied's scalable process aims to eliminate the lengthy and costly supply chains associated with traditional fertilizer production, facilitating a more circular farming system. This approach not only provides farmers with cost-effective and environmentally friendly fertilizer but also contributes to on-farm reductions in methane and ammonia emissions.

Ekkono Solutions AB specializes in developing machine learning solutions tailored for the Internet of Things (IoT). The company provides an embedded advanced analytics engine that enables connected devices to execute various machine learning techniques, managing the entire workflow from data input and model training to execution and re-training. Ekkono's technology allows for real-time processing of data at the edge of the network, facilitating proactive maintenance, operational optimization, and enhanced product intuitiveness. Its solutions cater to a wide range of industries, including energy, telecommunications, automotive, agriculture, healthcare, and housing automation, as well as consumer IoT applications such as home security systems and smart appliances. Founded on seven years of research at the University of Borås, Ekkono's innovations help clients effectively manage data volume and improve the performance of their IoT implementations. The company is headquartered in Tvååker, Sweden.

Ekkono Solutions AB specializes in developing machine learning solutions tailored for the Internet of Things (IoT). The company provides an embedded advanced analytics engine that enables connected devices to execute various machine learning techniques, managing the entire workflow from data input and model training to execution and re-training. Ekkono's technology allows for real-time processing of data at the edge of the network, facilitating proactive maintenance, operational optimization, and enhanced product intuitiveness. Its solutions cater to a wide range of industries, including energy, telecommunications, automotive, agriculture, healthcare, and housing automation, as well as consumer IoT applications such as home security systems and smart appliances. Founded on seven years of research at the University of Borås, Ekkono's innovations help clients effectively manage data volume and improve the performance of their IoT implementations. The company is headquartered in Tvååker, Sweden.

AcouSort AB is a Swedish company focused on developing and selling laboratory products and integrated OEM solutions that utilize ultrasound technology for the separation, washing, and enrichment of biological particles such as cells and exosomes. The company specializes in automated sample preparation for researchers and life science firms, leveraging acoustofluidics technology derived from research at Lund University's Department of Biomedical Engineering. AcouSort's product offerings include AcouTrap, which isolates microscopic particles, AcouWash for washing samples, and AcouPlasma, designed for plasma separation. Through its innovative solutions, AcouSort aims to enhance research and diagnostic processes in the life sciences sector.

Reliefed Technologies AB, based in Varberg, Sweden, specializes in producing 3D printing components for various manufacturing sectors, including transportation, building materials, consumer products, and energy applications. The company has developed a globally patented 3D-production method called z.trusion®, which allows for the integration of 3D mass production into existing 2D production lines. This innovative technology significantly reduces energy consumption and costs, particularly in the new energy sector, where it can achieve up to 97% less energy usage and ten times higher production speeds. Reliefed Technologies focuses on advanced applications such as bipolar flow plates for fuel cells and electrolyzers, electrodes for lithium-ion batteries, and other energy-efficient solutions. The company is actively involved in industrialization projects with major multinational OEMs and Tier 1 suppliers, holding 44 patents across multiple countries. Through its technology, Reliefed aims to improve product performance and facilitate recycling, while also contributing to substantial savings in material and production costs.

Oivi is a Norwegian company founded in 2017 and based in Oslo, specializing in the development of an affordable AI-driven camera and platform for the identification of diabetic eye diseases. The company focuses on facilitating retinal screening in primary care settings, thereby promoting awareness and proactive management of diabetic eye health. Oivi's innovative platform employs automated image capture and diagnostic capabilities to monitor eye diseases effectively through teleconsultation. With a multifaceted team possessing extensive expertise in camera and software development, Oivi aims to empower patients to prevent permanent vision loss associated with diabetes.

Quanturi Oy is a Finnish company founded in 2016, headquartered in Espoo, with additional locations across Europe, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium. The company specializes in developing and providing continuous monitoring solutions for fermentable products, focusing on sectors such as agriculture, forestry, and waste management. Its product offerings include wireless monitoring systems for compost temperature, grain management, and hay, as well as temperature monitoring systems applicable to various other industries. Quanturi Oy also engages in online sales of its innovative solutions, emphasizing the analysis of data associated with its connected objects.

Abzu is a company that develops a scientific artificial intelligence platform aimed at accelerating drug discovery and bringing pharmaceuticals to market more efficiently. Founded in January 2018, with offices in Copenhagen, Denmark, and Barcelona, Spain, Abzu challenges traditional, opaque AI methods by utilizing its pioneering technology, the QLattice. This platform provides transparent and explainable models that enable data scientists to approach their work with a scientific mindset. By unlocking new disease mechanisms, discovering novel biomarkers, and designing improved drugs, Abzu empowers pharmaceutical and biotech companies to validate multiple targets simultaneously, thereby enhancing their research capabilities and reducing development costs.

Quanturi Oy is a Finnish company founded in 2016, headquartered in Espoo, with additional locations across Europe, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium. The company specializes in developing and providing continuous monitoring solutions for fermentable products, focusing on sectors such as agriculture, forestry, and waste management. Its product offerings include wireless monitoring systems for compost temperature, grain management, and hay, as well as temperature monitoring systems applicable to various other industries. Quanturi Oy also engages in online sales of its innovative solutions, emphasizing the analysis of data associated with its connected objects.

Reliefed Technologies AB, based in Varberg, Sweden, specializes in producing 3D printing components for various manufacturing sectors, including transportation, building materials, consumer products, and energy applications. The company has developed a globally patented 3D-production method called z.trusion®, which allows for the integration of 3D mass production into existing 2D production lines. This innovative technology significantly reduces energy consumption and costs, particularly in the new energy sector, where it can achieve up to 97% less energy usage and ten times higher production speeds. Reliefed Technologies focuses on advanced applications such as bipolar flow plates for fuel cells and electrolyzers, electrodes for lithium-ion batteries, and other energy-efficient solutions. The company is actively involved in industrialization projects with major multinational OEMs and Tier 1 suppliers, holding 44 patents across multiple countries. Through its technology, Reliefed aims to improve product performance and facilitate recycling, while also contributing to substantial savings in material and production costs.

Evoy is a Norwegian manufacturer of electric propulsion systems for speedboats, founded in 2018 and headquartered in Florø, Sogn og Fjordane. The company designs inboard and outboard electric motors that replace traditional diesel and gasoline engines, significantly lowering maintenance and operating costs. These electric systems operate silently, minimizing noise pollution in marine environments while providing strong performance and responsiveness. Evoy's innovative technology enables ferry and tour operators to meet sustainability goals and adhere to regulatory requirements, enhancing their operational efficiency and environmental impact.

Evoy is a Norwegian manufacturer of electric propulsion systems for speedboats, founded in 2018 and headquartered in Florø, Sogn og Fjordane. The company designs inboard and outboard electric motors that replace traditional diesel and gasoline engines, significantly lowering maintenance and operating costs. These electric systems operate silently, minimizing noise pollution in marine environments while providing strong performance and responsiveness. Evoy's innovative technology enables ferry and tour operators to meet sustainability goals and adhere to regulatory requirements, enhancing their operational efficiency and environmental impact.

Carbo Culture Oy is a Finnish company founded in 2016, based in Helsinki, specializing in the production of biochar from waste biomass. It employs a carbon sequestration process that captures carbon dioxide from the atmosphere, transforming orchard waste and other local biomass into high-quality biochar using patented reactors. This biochar serves dual purposes: it is utilized in agricultural and construction applications, enhancing soil properties by improving water and nutrient retention, and it also acts as a remediation agent for contaminated sites. In addition to producing biochar, the company's technology generates renewable energy and contributes to the creation of carbon credits, promoting environmentally sustainable practices in energy production and waste management.

Seaborg Technologies ApS, founded in 2014 and based in Copenhagen, Denmark, specializes in the development and operation of thorium-based molten salt reactors (MSR) aimed at producing safe, clean, and carbon-free nuclear energy. The company is focused on addressing future energy demands by offering innovative solutions that connect conventional nuclear reactors with the thorium fuel cycle. In addition to its reactor technologies, Seaborg develops waste burners that convert transuranic elements into green energy and creates software tools that provide computational assistance to other MSR companies. Through its compact and environmentally friendly reactors, Seaborg Technologies seeks to deliver energy at lower manufacturing costs while effectively managing nuclear waste.

Surgify is focused on the commercialization of an innovative technology designed for bone surgery, developed at Aalto University with support from the Finnish Funding Agency for Innovation. The company collaborates closely with the Neurosurgical Department of Helsinki University Central Hospital to ensure effective communication with clinicians. Surgify's technology aims to protect proximal soft structures during surgery, thereby minimizing complications such as bleeding, infections, and nerve injuries. This advancement not only enhances surgical safety but also aims to improve patient outcomes and quality of life by reducing suffering associated with these procedures.

Surgify is focused on the commercialization of an innovative technology designed for bone surgery, developed at Aalto University with support from the Finnish Funding Agency for Innovation. The company collaborates closely with the Neurosurgical Department of Helsinki University Central Hospital to ensure effective communication with clinicians. Surgify's technology aims to protect proximal soft structures during surgery, thereby minimizing complications such as bleeding, infections, and nerve injuries. This advancement not only enhances surgical safety but also aims to improve patient outcomes and quality of life by reducing suffering associated with these procedures.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.

Ocean Oasis is a Norwegian company founded in 2020, specializing in innovative solutions for freshwater production through a sustainable desalination platform powered by wave energy. Based in Oslo, the company has developed a flexible and robust technology that harnesses the power of ocean waves to produce desalinated water without relying on electricity generation. This environmentally friendly approach offers a competitive alternative to traditional diesel-driven desalination methods, promoting decarbonization efforts and reducing emissions. By leveraging Norway's offshore expertise, Ocean Oasis aims to provide an efficient and clean means of delivering fresh water to coastal regions where it is needed most.

Kaffe Bueno ApS is a Copenhagen-based company founded in 2016 that specializes in producing ingredients for cosmetics, functional foods, and nutraceuticals from coffee waste. Utilizing proprietary biotechnology and green chemistry, Kaffe Bueno focuses on upcycling post-consumption coffee by-products, such as spent coffee grounds, into valuable compounds. The company offers a range of products, including coffee oils, coffee flour, and coffee beans, aimed at enhancing health benefits while minimizing harmful emissions. By transforming perceptions of coffee, Kaffe Bueno seeks to highlight its potential beyond mere consumption, positioning coffee as a resource rich in health-enhancing properties. Through its innovative approach, Kaffe Bueno supports industrial coffee producers, cafes, hotels, and offices in maximizing the utility of coffee by-products.

Comptek Solutions Oy, founded in 2017 and based in Turku, Finland, specializes in advanced passivation technology for compound semiconductor devices. The company's proprietary Kontrox technology employs a quantum-level surface engineering process that produces defect-free crystalline surfaces for III-V-based semiconductors. This innovative approach addresses the challenges posed by oxidation, which can lead to significant performance and reliability issues in devices such as MicroLEDs, lasers, detectors, and power electronics. By enhancing device efficiency and simplifying manufacturing processes, Kontrox has demonstrated impressive results, including a 250% performance increase in MicroLEDs and a 90-fold reduction in power consumption. Comptek Solutions serves a diverse range of applications, including optoelectronics, power electronics, and radio frequency technologies, and has garnered recognition, including a Horizon2020 SME Phase I grant and a shortlist position in the inaugural Spinoff Prize competition by Nature Research.

Comptek Solutions Oy, founded in 2017 and based in Turku, Finland, specializes in advanced passivation technology for compound semiconductor devices. The company's proprietary Kontrox technology employs a quantum-level surface engineering process that produces defect-free crystalline surfaces for III-V-based semiconductors. This innovative approach addresses the challenges posed by oxidation, which can lead to significant performance and reliability issues in devices such as MicroLEDs, lasers, detectors, and power electronics. By enhancing device efficiency and simplifying manufacturing processes, Kontrox has demonstrated impressive results, including a 250% performance increase in MicroLEDs and a 90-fold reduction in power consumption. Comptek Solutions serves a diverse range of applications, including optoelectronics, power electronics, and radio frequency technologies, and has garnered recognition, including a Horizon2020 SME Phase I grant and a shortlist position in the inaugural Spinoff Prize competition by Nature Research.

Minalyze AB is a Swedish company specializing in the development of analytical instruments and software for the mining and exploration industries. Founded in 2010 and headquartered in Savedalen, Minalyze provides mobile analysis solutions that are designed to endure harsh environments. Their products enable the on-site analysis of drill samples, facilitating geological data visualization and acquisition. Minalyze offers its services at various locations worldwide, including dedicated Core Competence Centres. The company's instruments support both short-term scanning projects and long-term initiatives, providing mining and exploration companies with essential geological insights for specialized projects.

Edvince AB is a biotechnology company based in Lund, Sweden, founded in 2003. The company specializes in developing innovative therapies aimed at treating brain injuries resulting from strokes. With a focus on minimizing brain damage, Edvince's treatment is rooted in extensive research conducted by Professor Lars Edvinsson. The company's approach involves a new acute stroke therapy that addresses underlying factors and symptoms associated with strokes, thereby offering potential solutions to enhance patient outcomes across various stroke types.

DigiFarm is an ag-tech startup based in Hamar, Norway, founded in 2019. The company specializes in developing deep neural network models using high-resolution Sentinel-2 imagery to assist Norwegian farmers in optimizing their grain production. DigiFarm's platform integrates artificial intelligence and machine learning to provide a neural network model tailored for local conditions, along with a crop classification model that includes extensive yield data. This enables farmers to monitor crop growth more effectively and make informed, data-driven decisions.

Minalyze AB is a Swedish company specializing in the development of analytical instruments and software for the mining and exploration industries. Founded in 2010 and headquartered in Savedalen, Minalyze provides mobile analysis solutions that are designed to endure harsh environments. Their products enable the on-site analysis of drill samples, facilitating geological data visualization and acquisition. Minalyze offers its services at various locations worldwide, including dedicated Core Competence Centres. The company's instruments support both short-term scanning projects and long-term initiatives, providing mining and exploration companies with essential geological insights for specialized projects.

Heart Aerospace AB, established in 2018 with headquarters in Gothenburg, Sweden, and operations in Palo Alto, California, specializes in developing electric regional airliners certified for passenger flight. The company's mission is to facilitate swift, affordable, and sustainable travel for regional journeys worldwide. Their flagship aircraft, the ES-19, is a nineteen-passenger electric airliner designed with an operating range of 400 km, aiming to reduce fuel and maintenance costs compared to traditional aircraft while emitting zero operational emissions. Heart Aerospace targets commercial operation certification for the ES-19 by 2026.

Handiscover Sweden AB is an online booking platform specializing in accommodations for individuals with physical disabilities. Founded in 2014 by Sebastien Archambeaud in response to personal experiences as a parent of a child with a muscle disease, the company is headquartered in Malmö, Sweden. Handiscover features a distinctive classification system that allows users to select accommodations based on varying levels of mobility and physical needs. This community-based platform not only enables individuals with disabilities to find suitable vacation rentals but also assists companies and municipalities in gathering and presenting essential accessibility data. By focusing on the unique requirements of its users, Handiscover aims to enhance the travel experience for people with disabilities, making it easier for them to discover and book accessible holiday accommodations.

N2 Applied is a Norwegian technology company focused on enabling farmers to produce their own sustainable fertilizer through an innovative process that utilizes slurry, air, and electricity. The company is in the pre-commercial phase and has developed a technology that allows for the local production of nitrogen-rich fertilizer from liquid organic substrates, such as livestock manure. By integrating nitrogen from the atmosphere into these substrates, N2 Applied's solution not only enhances the nitrogen content but also mitigates ammonia loss and reduces greenhouse gas emissions. The company operates its head office in Oslo/Asker and maintains a test center in Svene, with additional branches in Wageningen and York. N2 Applied's scalable process aims to eliminate the lengthy and costly supply chains associated with traditional fertilizer production, facilitating a more circular farming system. This approach not only provides farmers with cost-effective and environmentally friendly fertilizer but also contributes to on-farm reductions in methane and ammonia emissions.

Sparrow Quantum Aps. is a Danish company focused on advancing quantum technology through the development of light-matter interfaces. It specializes in creating deterministic single-photon sources, which are essential for various quantum applications. The company boasts the highest efficiency in on-chip single-photon sources globally, characterized by superior photon purity, indistinguishability, and outcoupling capabilities. This innovative technology is the culmination of over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which Sparrow Quantum holds exclusive licenses to key patents. By leveraging self-assembled quantum dots integrated with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interaction, providing clients with advanced solutions for their quantum technology needs.

MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

Carbo Culture Oy is a Finnish company founded in 2016, based in Helsinki, specializing in the production of biochar from waste biomass. It employs a carbon sequestration process that captures carbon dioxide from the atmosphere, transforming orchard waste and other local biomass into high-quality biochar using patented reactors. This biochar serves dual purposes: it is utilized in agricultural and construction applications, enhancing soil properties by improving water and nutrient retention, and it also acts as a remediation agent for contaminated sites. In addition to producing biochar, the company's technology generates renewable energy and contributes to the creation of carbon credits, promoting environmentally sustainable practices in energy production and waste management.

Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.

NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.

CrayoNano, founded in 2012 and headquartered in Trondheim, Norway, specializes in the development and manufacturing of nanomaterials-based semiconductor components. The company employs proprietary technologies to create innovative light-emitting diodes (LEDs) that produce ultraviolet light. Their patented vertically aligned nano-wires on graphene enhance critical performance metrics such as internal quantum efficiency, operating lifetime, and reliability. CrayoNano's semiconductor components contribute to various global solutions, particularly in health and safety, water purification, and both consumer and industrial applications, supporting a commitment to fostering more sustainable and healthier lives.

Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, specializing in hydration monitoring technology. Founded in 2016, the company has developed innovative wearable solutions, notably its flagship product, Re:Balans®, which allows for real-time, non-invasive tracking of fluid balance. This technology is designed to assist healthcare providers in assessing patients' hydration status, enabling early intervention and improved health outcomes. Mode Sensors' solutions are applicable across various sectors, including healthcare, defense, and workforce safety, and they integrate with existing remote patient monitoring systems. By focusing on user-friendly design and continuous innovation, Mode Sensors aims to optimize hydration management and enhance overall well-being and performance in diverse environments.

Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, specializing in hydration monitoring technology. Founded in 2016, the company has developed innovative wearable solutions, notably its flagship product, Re:Balans®, which allows for real-time, non-invasive tracking of fluid balance. This technology is designed to assist healthcare providers in assessing patients' hydration status, enabling early intervention and improved health outcomes. Mode Sensors' solutions are applicable across various sectors, including healthcare, defense, and workforce safety, and they integrate with existing remote patient monitoring systems. By focusing on user-friendly design and continuous innovation, Mode Sensors aims to optimize hydration management and enhance overall well-being and performance in diverse environments.

Heart Aerospace AB, established in 2018 with headquarters in Gothenburg, Sweden, and operations in Palo Alto, California, specializes in developing electric regional airliners certified for passenger flight. The company's mission is to facilitate swift, affordable, and sustainable travel for regional journeys worldwide. Their flagship aircraft, the ES-19, is a nineteen-passenger electric airliner designed with an operating range of 400 km, aiming to reduce fuel and maintenance costs compared to traditional aircraft while emitting zero operational emissions. Heart Aerospace targets commercial operation certification for the ES-19 by 2026.

CrayoNano, founded in 2012 and headquartered in Trondheim, Norway, specializes in the development and manufacturing of nanomaterials-based semiconductor components. The company employs proprietary technologies to create innovative light-emitting diodes (LEDs) that produce ultraviolet light. Their patented vertically aligned nano-wires on graphene enhance critical performance metrics such as internal quantum efficiency, operating lifetime, and reliability. CrayoNano's semiconductor components contribute to various global solutions, particularly in health and safety, water purification, and both consumer and industrial applications, supporting a commitment to fostering more sustainable and healthier lives.

Electrochaea GmbH is a German company specializing in the development and commercialization of innovative power-to-gas energy storage technology. Founded in 2010 and headquartered in Planegg, Germany, with additional facilities in Denmark and California, Electrochaea's proprietary biocatalytic process converts low-cost electricity and carbon dioxide into pipeline-grade renewable methane, the primary component of natural gas. This technology enables the efficient storage of renewable energy generated from sources like wind and solar, facilitating grid balancing and carbon recycling. By converting stranded electricity into renewable gas, Electrochaea provides a solution for utility-scale energy storage and supports the decarbonization of transportation and natural gas grids. The company aims to enhance existing infrastructure for energy transmission and contribute to a more sustainable energy landscape.

IQM Quantum Computers, founded in 2018 and headquartered in Espoo, Finland, specializes in developing and manufacturing hardware systems for quantum computing. The company focuses on scalable hardware solutions utilizing superconducting technology to build quantum processors for universal quantum computers. By concentrating on practical applications, IQM aims to enhance quantum computing capabilities and address challenges faced by various industries and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has achieved significant advancements in areas such as thermal management, which are crucial for improving computational speed and information accuracy. The company's innovations position it as a leader in the global pursuit of large-scale quantum computing solutions. IQM also offers access to its hardware for research laboratories and supercomputing centers, helping businesses reduce error rates that currently limit computing performance.

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company based in Turku, Finland, focused on developing novel treatments for medical conditions with significant unmet needs. The company has a diverse pipeline that addresses acute trauma, cancer, and inflammatory diseases. Its lead product, Traumakine, is an investigational intravenous formulation of interferon beta-1a, currently undergoing Phase III clinical trials for treating acute respiratory distress syndrome (ARDS). Another key candidate, Clevegen, is an immunotherapy designed to prevent tumor growth and metastasis by targeting immune suppressor molecules in tumors, and is in Phase I/II development. Additionally, Faron is developing D-ARDS, a diagnostic tool aimed at assessing ARDS severity and monitoring outcomes. The company collaborates with the MediCity unit of Turku University Medical School to enhance its research and development efforts. Founded in 2003, Faron Pharmaceuticals is committed to advancing innovative solutions in healthcare.

Ilya Pharma AB, established in 2016 and headquartered in Uppsala, Sweden, specializes in developing biological drugs for treating skin and mucosal wounds. The company's innovative approach involves genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that accelerate wound healing. Ilya Pharma focuses on both acute and chronic wounds, with a particular emphasis on addressing the unique challenges faced by diabetic patients.

Ilya Pharma AB, established in 2016 and headquartered in Uppsala, Sweden, specializes in developing biological drugs for treating skin and mucosal wounds. The company's innovative approach involves genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that accelerate wound healing. Ilya Pharma focuses on both acute and chronic wounds, with a particular emphasis on addressing the unique challenges faced by diabetic patients.

Electrochaea GmbH is a German company specializing in the development and commercialization of innovative power-to-gas energy storage technology. Founded in 2010 and headquartered in Planegg, Germany, with additional facilities in Denmark and California, Electrochaea's proprietary biocatalytic process converts low-cost electricity and carbon dioxide into pipeline-grade renewable methane, the primary component of natural gas. This technology enables the efficient storage of renewable energy generated from sources like wind and solar, facilitating grid balancing and carbon recycling. By converting stranded electricity into renewable gas, Electrochaea provides a solution for utility-scale energy storage and supports the decarbonization of transportation and natural gas grids. The company aims to enhance existing infrastructure for energy transmission and contribute to a more sustainable energy landscape.

Evoy is a Norwegian manufacturer of electric propulsion systems for speedboats, founded in 2018 and headquartered in Florø, Sogn og Fjordane. The company designs inboard and outboard electric motors that replace traditional diesel and gasoline engines, significantly lowering maintenance and operating costs. These electric systems operate silently, minimizing noise pollution in marine environments while providing strong performance and responsiveness. Evoy's innovative technology enables ferry and tour operators to meet sustainability goals and adhere to regulatory requirements, enhancing their operational efficiency and environmental impact.

Evoy is a Norwegian manufacturer of electric propulsion systems for speedboats, founded in 2018 and headquartered in Florø, Sogn og Fjordane. The company designs inboard and outboard electric motors that replace traditional diesel and gasoline engines, significantly lowering maintenance and operating costs. These electric systems operate silently, minimizing noise pollution in marine environments while providing strong performance and responsiveness. Evoy's innovative technology enables ferry and tour operators to meet sustainability goals and adhere to regulatory requirements, enhancing their operational efficiency and environmental impact.

Handiscover Sweden AB is an online booking platform specializing in accommodations for individuals with physical disabilities. Founded in 2014 by Sebastien Archambeaud in response to personal experiences as a parent of a child with a muscle disease, the company is headquartered in Malmö, Sweden. Handiscover features a distinctive classification system that allows users to select accommodations based on varying levels of mobility and physical needs. This community-based platform not only enables individuals with disabilities to find suitable vacation rentals but also assists companies and municipalities in gathering and presenting essential accessibility data. By focusing on the unique requirements of its users, Handiscover aims to enhance the travel experience for people with disabilities, making it easier for them to discover and book accessible holiday accommodations.

Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

IQM Quantum Computers, founded in 2018 and headquartered in Espoo, Finland, specializes in developing and manufacturing hardware systems for quantum computing. The company focuses on scalable hardware solutions utilizing superconducting technology to build quantum processors for universal quantum computers. By concentrating on practical applications, IQM aims to enhance quantum computing capabilities and address challenges faced by various industries and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has achieved significant advancements in areas such as thermal management, which are crucial for improving computational speed and information accuracy. The company's innovations position it as a leader in the global pursuit of large-scale quantum computing solutions. IQM also offers access to its hardware for research laboratories and supercomputing centers, helping businesses reduce error rates that currently limit computing performance.

MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

Modvion AB is a Swedish company founded in 2015 and based in Gothenburg, specializing in the design and development of modular wind power towers constructed from renewable composite materials. The company focuses on simplifying construction logistics and improving cost efficiency in the wind energy sector through its patented modular technology. This innovative approach enables the production of wind towers exceeding 120 meters in height while significantly reducing transportation costs, installation complexity, and the reliance on traditional steel structures. By leveraging engineered wood products, Modvion aims to enhance the economic viability of wind power projects, ultimately contributing to increased electricity production and more sustainable energy solutions.

Modvion AB is a Swedish company founded in 2015 and based in Gothenburg, specializing in the design and development of modular wind power towers constructed from renewable composite materials. The company focuses on simplifying construction logistics and improving cost efficiency in the wind energy sector through its patented modular technology. This innovative approach enables the production of wind towers exceeding 120 meters in height while significantly reducing transportation costs, installation complexity, and the reliance on traditional steel structures. By leveraging engineered wood products, Modvion aims to enhance the economic viability of wind power projects, ultimately contributing to increased electricity production and more sustainable energy solutions.

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company based in Turku, Finland, focused on developing novel treatments for medical conditions with significant unmet needs. The company has a diverse pipeline that addresses acute trauma, cancer, and inflammatory diseases. Its lead product, Traumakine, is an investigational intravenous formulation of interferon beta-1a, currently undergoing Phase III clinical trials for treating acute respiratory distress syndrome (ARDS). Another key candidate, Clevegen, is an immunotherapy designed to prevent tumor growth and metastasis by targeting immune suppressor molecules in tumors, and is in Phase I/II development. Additionally, Faron is developing D-ARDS, a diagnostic tool aimed at assessing ARDS severity and monitoring outcomes. The company collaborates with the MediCity unit of Turku University Medical School to enhance its research and development efforts. Founded in 2003, Faron Pharmaceuticals is committed to advancing innovative solutions in healthcare.

Oivi is a Norwegian company founded in 2017 and based in Oslo, specializing in the development of an affordable AI-driven camera and platform for the identification of diabetic eye diseases. The company focuses on facilitating retinal screening in primary care settings, thereby promoting awareness and proactive management of diabetic eye health. Oivi's innovative platform employs automated image capture and diagnostic capabilities to monitor eye diseases effectively through teleconsultation. With a multifaceted team possessing extensive expertise in camera and software development, Oivi aims to empower patients to prevent permanent vision loss associated with diabetes.

Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.

Colzyx AB is a biotechnology company based in Lund, Sweden, founded in 2012, specializing in innovative wound care solutions. The company leverages groundbreaking research from the Medical Faculty at Lund University, focusing on the alpha-3 chain of human collagen VI, which has shown significant wound healing and antimicrobial properties. Colzyx develops bioactive wound dressings that harness these biological mechanisms to enhance the wound healing process while effectively combating a wide range of bacteria, including multidrug-resistant strains. Their products are designed to treat both active and chronic wounds, promoting rapid closure and reducing the risk of infections, thereby improving patient outcomes.

NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.

NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.

Colzyx AB is a biotechnology company based in Lund, Sweden, founded in 2012, specializing in innovative wound care solutions. The company leverages groundbreaking research from the Medical Faculty at Lund University, focusing on the alpha-3 chain of human collagen VI, which has shown significant wound healing and antimicrobial properties. Colzyx develops bioactive wound dressings that harness these biological mechanisms to enhance the wound healing process while effectively combating a wide range of bacteria, including multidrug-resistant strains. Their products are designed to treat both active and chronic wounds, promoting rapid closure and reducing the risk of infections, thereby improving patient outcomes.

Aiforia Technologies, established in 2013 as a spin-off from the University of Helsinki's Finnish Institute for Molecular Medicine, specializes in cloud-based microscopy and pathology solutions driven by deep learning AI and high-performance computing. The company assists pathologists and scientists in efficiently analyzing medical images across various fields such as oncology and neuroscience, enabling accurate diagnoses and facilitating new discoveries.

SSH Communications Security Oyj specializes in enterprise cybersecurity solutions aimed at helping organizations, particularly in the financial sector, manage and secure access to critical data, applications, and services globally. Founded in 1995 by Tatu Ylönen, who developed the widely adopted Secure Shell protocol, the company offers a range of products, including PrivX for access management in multi-cloud environments, Universal SSH Key Manager for managing SSH keys and certificates, Tectia SSH for secure file transfers and remote administration, and NQX Firewall for high-security applications. With a customer base exceeding 3,000 worldwide, SSH Communications Security focuses on providing security, compliance, and operational efficiency in complex enterprise environments. The company operates through direct sales and online channels, deriving a significant portion of its revenue from Finland while serving clients across various regions, including the Americas, Asia-Pacific, Europe, and the Middle East.

RePack is a Finnish company founded in 2013, specializing in sustainable and reusable packaging solutions for online retailers and consumers. Based in Helsinki with a facility in the United States, RePack manufactures packaging bags made from durable materials such as polypropylene, polyethylene, and cardboard. These bags can be conveniently returned via local postal systems, allowing customers to recycle them while receiving vouchers for future purchases at participating stores. This innovative approach not only enhances the customer experience but also promotes sustainability by reducing waste and carbon emissions. RePack's service is designed for any online retailer aiming to demonstrate a commitment to environmental responsibility while engaging customers in sustainable practices.

Imaqen Ltd. is a Finnish healthcare technology company developing a new pre-screening solution for early detection of cancer. The innovation offers a non-invasive patient examination and it is suitable for use in wide range of healthcare facilities. The utilised method is protected by patents. Their team consists of experienced diagnostic imaging and clinical research professionals with solid track records in successful product development and global sales and marketing.

Valtavalo Ltd, established in 2008, specializes in the development, manufacture, and supply of energy-efficient lighting solutions in Finland and internationally. Recognized as the largest LED tube manufacturer in the Northern Countries, the company focuses on high-volume production to offer competitive pricing on advanced LED technologies, which have traditionally been perceived as costly. Valtavalo's product range includes long-lifetime LED lighting tubes equipped with replaceable light sources, allowing users to significantly lower their energy consumption, installation, and maintenance costs. Through its innovative approach, Valtavalo aims to make energy-efficient lighting accessible and affordable for a wide array of clients.

Medicortex Finland is focused on developing a non-invasive, point-of-care diagnostic test for Traumatic Brain Injury (TBI) and concussions. Traditional diagnostic methods, such as CT and MRI scans, struggle to accurately diagnose mild TBIs. To address this, Medicortex is identifying brain injury biomarkers that can be detected from urine and saliva, with plans to incorporate these biomarkers into a hand-held diagnostic kit that provides rapid and reliable results without the need for medical professionals' interpretation. The company aims to collaborate with larger diagnostic firms for manufacturing and distribution. Its target customers include hospitals, emergency rooms, paramedics, military personnel, sports teams, pharmaceutical companies, and insurance providers. Medicortex has achieved significant milestones, including reaching Phase II clinical studies for its biomarker and receiving grant funding from the US Department of Defense, the European Union, and the Finnish Government.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.